Inspired By Nature – Motivated by Health

At rAAVen Therapeutics we are driven by our curiosity and dedication. We want to help pave the way for Next generation of gene therapies. At rAAVen we have the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders.  Using state of the art methodologies within cloning, virus variant production and sequencing, we build novel viral vectors for precision targeting of defined cell populations or with desired properties.

What we offer

Unique approach

AAV Peptide display, combined with unique DNA barcoding and next generation sequencing allows for easy screening of AAV libraries containing millions of rationally designed, targeted AAV variants in a single screen.

Fast & Flexible

Choose your target, tissue type, cell population or application. rAAVen designs a targeted, rationally designed AAV peptide display library which can be combined by a generated library of promotor & enhancer elements for increased cell and tissue specific expression.

Translational at scale

rAAVen offers screening of the AAV peptide library in animal models ranging from rodents to non-human primates, ensuring that the delivered product translates within mammalian species and are prime candidates for clinical trials.

Never uninspired

Never uninspired

At rAAVen Therapeutics we are driven by our curiosity and dedication. We want to help pave the way for Next generation of gene therapies. With over two and a half decades of combined AAV engineering experience, our scientific leadership team has the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders.

Discover more
a

Complete dedication

Complete dedication

rAAVen therapeutics utilizes state-of-the-art methodologies within cloning, DNA barcoding and sequencing to bring our clients AAV vectors for precision targeting of tissue types, cell populations and specific applications.

Discover more
a

Flawless precision

Flawless precision

Our rAAptr platform is based on a unique, streamlined rational design approach, mimicking the protein-protein interactions evolved by nature. Tailored to the exact need of our clients, we are able to deliver an optimized AAV product, often after a single round of selection.

Discover more
a

Moving ahead

Moving ahead

Follow our progress in our ever growing comprehensive library screens for targeted delivery into specific targets.

Follow our journey
a

Never uninspired

At rAAVen Therapeutics we are driven by our curiosity and dedication. We want to help pave the way for Next generation of gene therapies. With over two and a half decades of combined AAV engineering experience, our scientific leadership team has the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders.

Discover more
a

Complete dedication

rAAVen therapeutics utilizes state-of-the-art methodologies within cloning, DNA barcoding and sequencing to bring our clients AAV vectors for precision targeting of tissue types, cell populations and specific applications.

Discover more
a

Flawless precision

Our rAAptr platform is based on a unique, streamlined rational design approach, mimicking the protein-protein interactions evolved by nature. Tailored to the exact need of our clients, we are able to deliver an optimized AAV product, often after a single round of selection.

Discover more
a

Moving ahead

Follow our progress in our ever growing comprehensive library screens for targeted delivery into specific targets.

Follow our journey
a
For any given therapeutic problem, nature has most likely already created a solution, you just have to know where to look.
Patrick Aldrin-Kirk – CSO
It’s an incredibly exciting time to work in gene therapy right now, with a small but rapidly increasing number of approved therapies we continue our work towards improving the lives of patients.
Marcus Davidsson – Founder & COO